The differences between pure and mixed invasive micropapillary breast cancer: the epithelial-mesenchymal transition molecules and prognosis

被引:0
作者
Oz, Ozden [1 ]
Yuzuguldu, Resmiye Irmak [2 ]
Yazici, Ayse [3 ]
Cavdar, Demet Kocatepe [1 ]
Yilmaz, Cengiz [4 ]
Ozturk, Mucteba [5 ]
Duzel, Hilal [6 ]
Gurel, Duygu [7 ]
机构
[1] Univ Hlth Sci, Izmir Bozyaka Training & Res Hosp, Dept Pathol, Izmir, Turkiye
[2] Mugla Training & Res Hosp, Dept Pathol, Mugla, Turkiye
[3] Izmir Katip Celebi Univ, Training & Res Hosp, Fac Med, Dept Pathol, Izmir, Turkiye
[4] Univ Hlth Sci, Izmir Bozyaka Training & Res Hosp, Dept Med Oncol, Izmir, Turkiye
[5] Univ Hlth Sci, Izmir Bozyaka Training & Res Hosp, Dept Gen Surg, Izmir, Turkiye
[6] Dokuz Eylul Univ, Med Fac, Dept Publ Hlth, Izmir, Turkiye
[7] Dokuz Eylul Univ, Med Fac, Dept Pathol, Izmir, Turkiye
关键词
Pure breast micropapillary carcinoma; Epithelial-mesenchymal transition (EMT); Prognostic parameters; Prognosis; CARCINOMA; PROGRESSION; FEATURES; VARIANT;
D O I
10.1007/s10549-024-07384-w
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose Invasive micropapillary carcinoma (IMPC) of the breast is known for its high metastatic potential, but the definition of pure and mixed IMPC remains unclear. This retrospective cohort study aims to investigate the prognostic significance of the micropapillary component ratio and the expression of critical molecules of epithelial-mesenchymal transition (EMT), including E-cadherin (E-cad), N-cadherin (N-cad), CD44s, and beta-catenin (beta-cat), in distinguishing between pure and mixed IMPCs. Methods We analyzed 100 cases of locally advanced IMPC between 2000 and 2018 and excluded patients who received neoadjuvant chemotherapy. Pure IMPC was defined as having a micropapillary component of over 90%. A comprehensive recording of prognostic parameters was conducted. The IMPC areas were analyzed using the immunohistochemical (IHC) staining method on the microarray set for pure and mixed IMPC patients. Pearson's chi-square, Fisher's exact tests, Kaplan-Meier analysis, and Cox proportional hazards analysis were employed. Results The comparative survival analysis of the entire group, based on overall survival (OS) and disease-free survival (DFS), revealed no significant difference between the pure and mixed groups (P = 0.480, HR = 1.474 [0.502-4.325] and P = 0.390, HR = 1.587 [0.550-4.640], respectively). However, in the pure IMPC group, certain factors were found to be associated with a higher risk of short survival. These factors included skin involvement (P = 0.050), pT3&4 category (P = 0.006), a ratio of intraductal component (> 5%) (P = 0.032), and high-level expression of N-cad (P = 0.020). Notably, none of the risk factors identified for short OS in pure IMPC cases were observed as significant risks in mixed cases and vice versa. Furthermore, N-cad was identified as a poor prognostic marker for OS in pure IMPCs (P = 0.002). Conclusion The selection of a 90% ratio for classifying pure IMPCs revealed significant differences in certain molecular and prognostic parameters between pure and mixed groups. Notably, the involvement of N-cadherin in the epithelial-mesenchymal transition (EMT) process provided crucial insights for predicting OS and DFS while also distinguishing between the two groups. These findings strongly support the notion that the pure IMPC subgroup represents a distinct entity characterized by unique molecular characteristics and behavioral patterns.
引用
收藏
页码:41 / 55
页数:15
相关论文
共 50 条
[21]   TFDP3 Regulates Epithelial-Mesenchymal Transition in Breast Cancer [J].
Yin, Kailin ;
Liu, Yanchen ;
Chu, Ming ;
Wang, Yuedan .
PLOS ONE, 2017, 12 (01)
[22]   Adipocytes can induce epithelial-mesenchymal transition in breast cancer cells [J].
Lee, YuKyung ;
Jung, Woo Hee ;
Koo, Ja Seung .
BREAST CANCER RESEARCH AND TREATMENT, 2015, 153 (02) :323-335
[23]   Micropapillary colorectal carcinoma: clinical, pathological and molecular properties, including evidence of epithelial-mesenchymal transition [J].
Gonzalez, Raul S. ;
Huh, Won Jae ;
Cates, Justin M. M. ;
Washington, Kay ;
Beauchamp, R. Daniel ;
Coffey, Robert J. ;
Shi, Chanjuan .
HISTOPATHOLOGY, 2017, 70 (02) :223-231
[24]   FYN promotes breast cancer progression through epithelial-mesenchymal transition [J].
Xie, Ye-Gong ;
Yu, Yue ;
Hou, Li-Kun ;
Wang, Xin ;
Zhang, Bin ;
Cao, Xu-Chen .
ONCOLOGY REPORTS, 2016, 36 (02) :1000-1006
[25]   Role of the Epithelial-Mesenchymal Transition in Bladder Cancer: From Prognosis to Therapeutic Target [J].
Yun, Seok Joong ;
Kim, Wun-Jae .
KOREAN JOURNAL OF UROLOGY, 2013, 54 (10) :645-650
[26]   Epithelial-Mesenchymal Transition: Clinical Implications for Nodal Metastasis and Prognosis of Tongue Cancer [J].
Han, Myung Woul ;
Lee, Jong Cheol ;
Kim, Young Min ;
Cha, Hee Jeong ;
Roh, Jong-Lyel ;
Choi, Seung-Ho ;
Nam, Soon Yuhl ;
Cho, Kyung-Ja ;
Kim, Seong Who ;
Kim, Sang Yoon .
OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2015, 152 (01) :80-86
[27]   The Clinicopathological Characteristics of Pure and Mixed Invasive Micropapillary Breast Carcinomas: A Single Center Experience [J].
Kupik, Gulnihan Eren ;
Altundag, Kadri .
BALKAN MEDICAL JOURNAL, 2022, 39 (04) :275-281
[28]   An Epithelial-Mesenchymal Transition-Related LncRNA Signature Predicts Prognosis in Triple-Negative Breast Cancer [J].
Chen, Xuezhang ;
Chen, Xikang ;
Zhu, Zhixia ;
Chen, Yinsong ;
Pang, Xiaoqi ;
Zhong, Xianxun ;
You, Shuang ;
Chen, Yaoxu ;
Tian, Huaqin .
JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2023, 37 (02) :1063-1073
[29]   Association between the expression of epithelial-mesenchymal transition (EMT)-related markers and oncologic outcomes of colorectal cancer [J].
Emile, Mona Hany ;
Emile, Sameh Hany ;
El-Karef, Amr Awad ;
Ebrahim, Mohamed Awad ;
Mohammed, Ibrahim Eldosoky ;
Ibrahim, Dina Abdallah .
UPDATES IN SURGERY, 2024, 76 (06) :2181-2191
[30]   Implications of epithelial-mesenchymal transition in gastric cancer [J].
Tanabe, Shihori ;
Komatsu, Masayuki ;
Aoyagi, Kazuhiko ;
Yokozaki, Hiroshi ;
Sasaki, Hiroki .
TRANSLATIONAL GASTROINTESTINAL CANCER, 2015, 4 (04) :258-264